Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab pharmacogenetics study in age-related macular degeneration
ISRCTN44202629Phase 4Completed
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Mar 2009
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
01
Overview
Phase 4, open-label, single-arm trial of ranibizumab in exudative macular degeneration, sponsored by Leeds Teaching Hospitals NHS Trust. Started Mar 2009; status: completed.
02
Drugs
ranibizumab
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on ISRCTN44202629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN44202629.